[HTML][HTML] The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of View
F Mosna - Cancers, 2024 - mdpi.com
Simple Summary Despite significant advancements, acute myeloid leukemia (AML) still
remains characterized by a dismal prognosis in too many patients, and oftentimes, a cure …
remains characterized by a dismal prognosis in too many patients, and oftentimes, a cure …
[HTML][HTML] CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment
K Teppert, IEY Ogusuku, C Brandes, V Herbel… - Molecular Therapy …, 2024 - cell.com
Acute myeloid leukemia (AML), a fast-progressing hematological malignancy affecting
myeloid cells, is typically treated with chemotherapy or hematopoietic stem cell …
myeloid cells, is typically treated with chemotherapy or hematopoietic stem cell …